Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-09-06
4:54 pm
Purchase
13G2seventy bio, Inc.
TSVT
Kynam Capital Management LP5,953,825
11.7%
5,953,825increase
(New Position)
View
2023-03-21
5:40 pm
Sale
13GOlema Pharmaceuticals, Inc.
OLMA
Kynam Capital Management LP2,025,234
5%
-38,398,598decrease
(-94.99%)
View
2023-02-13
09:25 am
Unchanged
13GConcert Pharmaceuticals, Inc.
CNCE
Kynam Capital Management LP4,420,349
9.2%
0
(Unchanged)
View
2023-02-10
3:51 pm
Purchase
13GConcert Pharmaceuticals, Inc.
CNCE
Kynam Capital Management LP4,420,349
9.2%
4,420,349increase
(New Position)
View
2023-02-10
1:20 pm
Purchase
13GVera Therapeutics, Inc.
VERA
Kynam Capital Management LP1,409,098
5.1%
1,409,098increase
(New Position)
View
2023-02-10
1:18 pm
Purchase
13GOlema Pharmaceuticals, Inc.
OLMA
Kynam Capital Management LP40,423,832
5%
40,423,832increase
(New Position)
View
2023-02-10
1:16 pm
Purchase
13GBurning Rock Biotech Limited
BNR
Kynam Capital Management LP7,391,581
8.4%
7,391,581increase
(New Position)
View